Literature DB >> 9343240

The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

A Lieber1, C Y He, L Meuse, D Schowalter, I Kirillova, B Winther, M A Kay.   

Abstract

Systemic application of first-generation adenovirus induces pathogenic effects in the liver. To begin unraveling the mechanisms underlying early liver toxicity after adenovirus infusion, particularly the role of macrophage activation and expression of viral genes in transduced target cells, first-generation adenovirus or adenovirus vectors that lacked most early and late gene expression were administered to C3H/HeJ mice after transient depletion of Kupffer cells by gadolinium chloride treatment. Activation of NF-kappaB, and the serum levels of the proinflammatory cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) were studied in correlation with liver damage, apoptosis, and hepatocellular DNA synthesis. While Kupffer cell depletion nearly eliminated adenovirus-induced TNF release, it resulted in a more robust IL-6 release. These responses were greatly reduced in animals receiving the deleted adenovirus. Although there were quantitative differences, NF-kappaB activation was observed within minutes of first-generation or deleted adenovirus vector administration regardless of the status of the Kupffer cells, suggesting that the induction is related to a direct effect of the virus particle on the hepatocyte. Early liver toxicity as determined by serum glutamic-pyruvic transaminase elevation and inflammatory cell infiltrates appeared to be dependent on adenovirus-mediated early gene expression and intact Kupffer cell function. Kupffer cell depletion had little effect on adenovirus-mediated hepatocyte apoptosis but did increase hepatocellular DNA synthesis. Finally, Kupffer cell depletion decreased the persistence of transgene (human alpha1-antitrypsin [hAAT]) expression that was associated with a more pronounced humoral immune response against hAAT. The elucidation of these events occurring after intravenous adenovirus injection will be important in developing new vectors and transfer techniques with reduced toxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343240      PMCID: PMC192346     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity.

Authors:  M P Callery; T Kamei; M W Flye
Journal:  Arch Surg       Date:  1990-01

2.  The genetic mapping of a defective LPS response gene in C3H/HeJ mice.

Authors:  J Watson; K Kelly; M Largen; B A Taylor
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

Authors:  S Worgall; G Wolff; E Falck-Pedersen; R G Crystal
Journal:  Hum Gene Ther       Date:  1997-01-01       Impact factor: 5.695

4.  Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ.

Authors:  G Wolff; S Worgall; N van Rooijen; W R Song; B G Harvey; R G Crystal
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 5.  Regulation of apoptosis by viral gene products.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration.

Authors:  R P Cornell
Journal:  Am J Physiol       Date:  1985-11

7.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression.

Authors:  J T Bruder; I Kovesdi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.

Authors:  A Lieber; C Y He; I Kirillova; M A Kay
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.

Authors:  Y Ilan; G Droguett; N R Chowdhury; Y Li; K Sengupta; N R Thummala; A Davidson; J R Chowdhury; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

10.  NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.

Authors:  L C Sambucetti; J M Cherrington; G W Wilkinson; E S Mocarski
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  130 in total

1.  Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats.

Authors:  D S Steinwaerder; C A Carlson; A Lieber
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.

Authors:  A Lieber; D S Steinwaerder; C A Carlson; M A Kay
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.

Authors:  D B Schowalter; C L Himeda; B L Winther; C B Wilson; M A Kay
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types.

Authors:  Clare E Thomas; Penny Edwards; Thomas J Wickham; Maria G Castro; Pedro R Lowenstein
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.

Authors:  Jin Huk Choi; Joe Dekker; Stephen C Schafer; Jobby John; Craig E Whitfill; Christopher S Petty; Eid E Haddad; Maria A Croyle
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

9.  Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

Authors:  Sergey S Seregin; Daniel M Appledorn; Aaron J McBride; Nathaniel J Schuldt; Yasser A Aldhamen; Tyler Voss; Junping Wei; Matthew Bujold; William Nance; Sarah Godbehere; Andrea Amalfitano
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

10.  Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.

Authors:  Amy K LeBlanc; Shruthi Naik; Gina D Galyon; Nathan Jenks; Mike Steele; Kah-Whye Peng; Mark J Federspiel; Robert Donnell; Stephen J Russell
Journal:  Hum Gene Ther Clin Dev       Date:  2013-12       Impact factor: 5.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.